Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma

By Keam Bhumsuk   Kim Sung-Bae   Shin Seong Hoon   Cho Byoung Chul   Lee Keun-Wook   Kim Min Kyoung   Yun Hwan-Jung   Lee Se-Hoon   Yoon Dok Hyun   Bang Yung-Jue  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2612-2617

Blackwell Publishing

Access to resources Recommend Favorite

Phase II study of vinflunine in patients with metastatic renal cell carcinoma

By Goldstein D.   Ackland S.   Bell D.   Olver I.   Davis I.   Rosenthal M.   Toner G.   Pinel M.   Byrne M.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 429-434

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma

By Shaheen Philip   Stadler Walter   Elson Paul   Knox Jennifer   Winquist Eric   Bukowski Ronald  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 577-581

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)

By Bekaii-Saab Tanios   Mortazavi Amir   Hicks Lee   Zalupski Mark   Pelley Robert   Chan Kenneth   Kraut Eric  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 343-346

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

By Vuky Jacqueline   Isacson Christina   Fotoohi Mehran   Cruz Jason   Otero Henry   Picozzi Vincent   Malpass Thomas   Aboulafia David   Jacobs Andrew  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite